Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation
- PMID: 17914215
- DOI: 10.1007/s12011-007-0041-9
Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation
Abstract
Aim: Assess the risk of zinc (Zn) deficiency in the older cystic fibrosis (CF) population.
Method: Cross-sectional investigation of all CF patients above the age of 4 followed at the Ghent University center between 2002 and 2003. Data on age, weight, height z-score, pancreatic and pulmonary functions, chronic Pseudomonas infection, and CF transmembrane conductance regulator (CFTR) mutations were collected. Serum Zn, vitamins (vit) A and E, retinol-binding protein (RBP), albumin, sedimentation rate, total IgG, and cholesterol were determined. Serum Zn was compared with a local healthy control group (Van Biervliet et al., Biol Trace Elem Res 94:33-40, 2003) and with literature data (Hotz C, et al. Am J Clin Nutr 78:756-764, 2003).
Results: 101 patients (median age 16 years) were included. There was no difference in serum Zn concentration between CF patients and controls. In CF patients no difference in serum Zn concentration between pancreatic-sufficient or pancreatic-insufficient patients was seen. Serum Zn was not associated to nutritional status or height z-score. A significant association serum Zn to serum albumin (p < 0.0005) and to vit A (p < 0.01) was seen. No associations of serum Zn to serum vit E, RBP, cholesterol, or CFTR were present, but there is a significant association serum Zn to forced vital capacity (p < 0.01). Serum Zn was not associated to inflammatory parameters or chronic Pseudomonas infection.
Conclusion: Comparison of CF patients with local controls revealed no significant differences. However, because persisting steatorrhea increases Zn loss (Easley et al., J Pediatr Gastroenterol Nutr 26:136-139, 1998) and 12.6% of our population has a serum Zn below the p value of 2.5 of the NHANES II study (Hotz C, et al. Am J Clin Nutr 78:756-764, 2003), there could remain an increased risk of Zn deficiency in some CF patients. Furthermore, the association with pulmonary function needs more investigation.
Similar articles
-
Serum zinc in patients with cystic fibrosis at diagnosis and after one year of therapy.Biol Trace Elem Res. 2006 Sep;112(3):205-11. doi: 10.1385/BTER:112:3:205. Biol Trace Elem Res. 2006. PMID: 17057259
-
Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.Pediatrics. 2005 Apr;115(4):e463-9. doi: 10.1542/peds.2004-1764. Epub 2005 Mar 16. Pediatrics. 2005. PMID: 15772171
-
Serum zinc concentration in cystic fibrosis patients with CFTR I1234V mutation associated with pancreatic sufficiency.Clin Respir J. 2017 May;11(3):305-310. doi: 10.1111/crj.12335. Epub 2015 Jul 14. Clin Respir J. 2017. PMID: 26096753
-
Nutrition in cystic fibrosis.Semin Respir Crit Care Med. 2009 Oct;30(5):579-86. doi: 10.1055/s-0029-1238916. Epub 2009 Sep 16. Semin Respir Crit Care Med. 2009. PMID: 19760545 Review.
-
The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype.Eur J Gastroenterol Hepatol. 2008 Mar;20(3):157-60. doi: 10.1097/MEG.0b013e3282f36d16. Eur J Gastroenterol Hepatol. 2008. PMID: 18301292 Review.
Cited by
-
Zinc Deficiency via a Splice Switch in Zinc Importer ZIP2/SLC39A2 Causes Cystic Fibrosis-Associated MUC5AC Hypersecretion in Airway Epithelial Cells.EBioMedicine. 2018 Jan;27:304-316. doi: 10.1016/j.ebiom.2017.12.025. Epub 2017 Dec 20. EBioMedicine. 2018. PMID: 29289532 Free PMC article.
-
Zinc status in cystic fibrosis patients; a systematic review and meta-analysis.Heliyon. 2024 Jun 28;10(13):e33686. doi: 10.1016/j.heliyon.2024.e33686. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39027558 Free PMC article. Review.
-
The Role of Zinc in the Pathogenesis of Lung Disease.Nutrients. 2022 May 19;14(10):2115. doi: 10.3390/nu14102115. Nutrients. 2022. PMID: 35631256 Free PMC article. Review.
-
Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial.J Clin Med. 2023 May 26;12(11):3704. doi: 10.3390/jcm12113704. J Clin Med. 2023. PMID: 37297899 Free PMC article.
-
Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex.Nutrients. 2022 Nov 4;14(21):4666. doi: 10.3390/nu14214666. Nutrients. 2022. PMID: 36364928 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical